Diffuse large B-cell lymphoma in elderly: Experience from a tertiary care oncology center in South India

Diffuse large B-cell lymphoma in elderly: Experience from a tertiary care oncology center in South India

Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most frequent non-Hodgkins lymphoma in the elderly. With the rising proportion of older persons in India, it is important to study current patterns and management of this disease, given that data in this regard are scarce in Indian settings....

Full description

Bibliographic Details
Main Authors:	K N Lokesh, M C. Suresh Babu, K C Lakshmaiah, K Govind Babu, Smitha C Saldanha, D Loknatha, Linu Abraham Jacob, S Vishwanath, C S Premalatha, P R Kiran
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2017-01-01
Series:	South Asian Journal of Cancer
Subjects:	Cyclophosphamide diffuse large B-cell lymphoma doxorubicin India relapse remission rituximab vincristine prednisone
Online Access:	http://journal.sajc.org/article.asp?issn=2278-330X;year=2017;volume=6;issue=2;spage=72;epage=74;aulast=Lokesh

Similar Items

Germinal Centre-Related Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type: Report of a Remission Case
by: Liu F, et al.
Published: (2022-07-01)

Primary Central Nervous System Lymphoma: An Experience of a Regional Cancer Center from India
by: Budhi Singh Yadav, et al.
Published: (2019-01-01)

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma
by: K. Lisenko, et al.
Published: (2017-05-01)

Dual-Positive (CD4+/CD8+) Acute Adult T-Cell Leukemia/Lymphoma Associated with Complex Karyotype and Refractory Hypercalcemia: Case Report and Literature Review
by: Shahzad Raza, et al.
Published: (2010-12-01)

Phase II study of R–CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study
by: Sung Yong Oh, et al.
Published: (2019-10-01)

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
by: Frank B. Cortazar, et al.
Published: (2018-03-01)

Serum Albumin Levels Strongly Predict Survival Outcome of Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Combined Chemotherapy
by: Hiroto Kaneko, et al.
Published: (2022-01-01)

Use of Plasmapheresis and Immunosuppressants to Treat Diffuse Alveolar Hemorrhage in a Patient with Granulomatosis with Polyangiitis
by: Yasar Sattar, et al.
Published: (2019-07-01)

Adding low dose cyclophosphamide to rituximab for remission-induction may prolong relapse-free survival in patients with ANCA vasculitis: A retrospective study
by: Renée Ysermans, et al.
Published: (2023-01-01)

Rituximab - Progress but Still Not a Final Resolution for Pemphigus Patients: Clinical Report From a Single Center Study
by: Joško Miše, et al.
Published: (2022-05-01)

Adult Burkitt lymphoma: An institutional experience with a uniform chemotherapy protocol
by: Mukesh Patekar, et al.
Published: (2018-01-01)

Hemodynamic and Biochemical Alterations in Dogs with Lymphoma after Induction of Chemotherapy
by: D.M. Fine, et al.
Published: (2014-05-01)

The role of rituximab in the treatment of ANCA-associated vasculitides (AAV)
by: Thomas Daikeler, et al.
Published: (2015-01-01)

Continuous low-dose cyclophosphamide plus prednisone in the treatment of relapsed and refractory multiple myeloma with severe complications
by: Haotian Shi, et al.
Published: (2023-05-01)

Expression of Aberrant Markers and its Association with Remission Postinduction Therapy in Acute Lymphoblastic Leukaemia and Acute Myeloid Leukaemia
by: Subbaramaiah Shwetha, et al.
Published: (2021-07-01)

Rituximab Therapy for Severe Cutaneous Leukocytoclastic Angiitis Refractory to Corticosteroids, Cellcept and Cyclophosphamide
by: Kamel El-Reshaid, et al.
Published: (2013-04-01)

Cyclophosphamide Versus Rituximab in Progressive Forms of Multiple Sclerosis
by: Masoud Etemadifar, et al.
Published: (2020-02-01)

Comparison of the efficacy of steroid-free versus classic steroid-containing regimens in primary membranous nephropathy
by: Hui-Lin Xing, et al.
Published: (2024-02-01)

Comparison of rituximab, cyclophosphamide, and tacrolimus as first steroid-sparing agents for complicated relapsing/steroid-dependent nephrotic syndrome in children: an evaluation of the health-related quality of life
by: Li Wang, et al.
Published: (2022-01-01)

A novel approach to rapid induction of remission in primary membranous nephropathy
by: Vladimir A. Dobronravov, et al.
Published: (2021-06-01)

The Efficacy of Cyclophosphamide Combined with Prednisone in Membranous Nephropathy Patients with Different Cytochrome P450 2B6 Gene Polymorphisms and Analysis of Factors Influencing the Efficacy
by: Zhang M, et al.
Published: (2022-10-01)

Molecular mechanisms of apoptosis induction in murine lymphoma NK/Ly under chemotherapy in vivo
by: R. R. Panchuk, et al.
Published: (2009-04-01)

Enhancing the Impact of Chemotherapy on Ewing Sarcoma Cells through Combination with Cold Physical Plasma
by: Andreas Nitsch, et al.
Published: (2023-05-01)

Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System
by: Taurean Brown, et al.
Published: (2021-02-01)

Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly
by: Roberta Fenoglio, et al.
Published: (2020-10-01)

Autoimmune Pancreatitis: A Case of Atypical Radiographic Findings
by: Shawhin Karimi, et al.
Published: (2016-10-01)

Plasmablastic lymphoma in immunocompetent and in immunocompromised patients: Experience at a regional cancer centre in India
by: A H Rudresha, et al.
Published: (2017-01-01)

Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy
by: Yaling Guo, et al.
Published: (2020-01-01)

A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis
by: Jack Arnold, et al.
Published: (2022-01-01)

Recurrent autoimmune hemolytic anemia in splenic marginal zone lymphoma
by: Oreoluwa Oladiran, et al.
Published: (2018-07-01)

A clinical case of early successful diagnosis and treatment of relapsing polychondritis
by: E. N. Sukhikh, et al.
Published: (2019-01-01)

Evaluate the Response Rate of Acute Lymphocytic Leukemia Patients to Hyper Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone Regimen and Remission Rate to Stay Until the End of the Arbitrary Treatment
by: Valiollah Mehrzad, et al.
Published: (2018-01-01)

The efficacy of low dose short-term prednisone therapy for remission induction in newly diagnosed rheumatoid arthritis patients
by: John M. Stacy, et al.
Published: (2021-08-01)

Pulmonary involvement in Anti‐Neutrophil Cytoplasmic Antibody Associated Vasculitis: A single centre case series
by: Peter T. Bell, et al.
Published: (2022-11-01)

A comparative study to evaluate the efficacy and cost of rituximab versus dexamethasone cyclophosphamide pulse in patients of pemphigus vulgaris
by: Sudip Das, et al.
Published: (2021-01-01)

Chromonychia Secondary to Chemotherapy
by: Marien Lopes, et al.
Published: (2013-06-01)

A case of doxorubicin and cyclophosphamide therapy-induced type 1 diabetes: a case report
by: Makoto Miyabayashi, et al.
Published: (2023-01-01)

Cyclophosphamide in the treatment of focal segmental glomerulosclerosis
by: R. Martinelli, et al.
Published: (2004-09-01)

Pharmacoeconomic benefit of cisplatin and etoposide chemoregimen for metastatic non small cell lung cancer: An Indian study
by: Mangesh P Kamath, et al.
Published: (2016-01-01)

Clinical efficacy and safety of rituximab with membranous nephropathy: a meta-analysis
by: Hongzhen Zhong, et al.
Published: (2020-10-01)